{"count": 6, "results": [{"_id": "35767209", "pmid": 35767209, "title": "Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.", "journal": "Geroscience", "authors": ["Williams JM", "Murphy SR", "Wu W", "Border JJ", "Fan F", "Roman RJ"], "date": "2022-12-01T00:00:00Z", "doi": "10.1007/s11357-022-00610-7", "meta_date_publication": "2022 Dec", "meta_volume": "44", "meta_issue": "6", "meta_pages": "2845-2861", "score": 50247.6, "text_hl": "The present study examined if controlling @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ with @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@, or given in combination with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, slows the progression of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@renal injury@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive diabetic@@@ @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Williams JM, Murphy SR, Wu W, Border JJ, Fan F, Roman RJ. Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension. Geroscience. 2022 Dec;44(6):2845-2861. PMID: 35767209", "BibTeX": "@article{35767209, title={Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.}, author={Williams JM and Murphy SR and Wu W and Border JJ and Fan F and Roman RJ}, journal={Geroscience}, volume={44}, number={6}, pages={2845-2861}}"}}, {"_id": "18491582", "pmid": 18491582, "title": "[Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome].", "journal": "Ter Arkh", "authors": ["Shevchenko OP", "Praskurnichiĭ EA", "Savel'eva SA"], "date": "2008-01-01T00:00:00Z", "meta_date_publication": "2008", "meta_volume": "80", "meta_issue": "4", "meta_pages": "54-9", "score": 50062.97, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ monotherapy improved @CHEMICAL_Carbohydrates @CHEMICAL_MESH:D002241 @@@carbohydrate@@@ metabolism as shown by reduction of postprandial @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@hyperinsulinemia@@@ in @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@MS@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Shevchenko OP, Praskurnichiĭ EA, Savel'eva SA. [Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome]. Ter Arkh. 2008;80(4):54-9. PMID: 18491582", "BibTeX": "@article{18491582, title={[Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome].}, author={Shevchenko OP and Praskurnichiĭ EA and Savel'eva SA}, journal={Ter Arkh}, volume={80}, number={4}, pages={54-9}}"}}, {"_id": "26169541", "pmid": 26169541, "pmcid": "PMC4552522", "title": "Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats", "journal": "Physiol Rep", "authors": ["Kojima N", "Williams JM", "Slaughter TN", "Kato S", "Takahashi T", "Miyata N", "Roman RJ"], "date": "2015-07-01T00:00:00Z", "doi": "10.14814/phy2.12436", "meta_date_publication": "2015 Jul", "meta_volume": "3", "meta_issue": "7", "meta_pages": "", "score": 50056.21, "text_hl": "These results suggest that long-term control of @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ with @CHEMICAL_1_5_anhydro_1_(5_(4_ethoxybenzyl)_2_methoxy_4_methylphenyl)_1_thioglucitol @CHEMICAL_MESH:C549343 @@@luseogliflozin@@@, especially in combination with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ to lower blood pressure, attenuates the development of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@renal injury@@@ in this @SPECIES_10116 @@@rat@@@ model of advanced @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@.", "citations": {"NLM": "Kojima N, Williams JM, Slaughter TN, Kato S, Takahashi T, Miyata N, Roman RJ. Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats Physiol Rep. 2015 Jul;3(7):. PMID: 26169541", "BibTeX": "@article{26169541, title={Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats}, author={Kojima N and Williams JM and Slaughter TN and Kato S and Takahashi T and Miyata N and Roman RJ}, journal={Physiol Rep}, volume={3}, number={7}}"}}, {"_id": "9076844", "pmid": 9076844, "title": "Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.", "journal": "Pharmacol Res", "authors": ["Sevak AR", "Goyal RK"], "date": "1996-11-01T00:00:00Z", "doi": "10.1006/phrs.1996.0089", "meta_date_publication": "1996 Nov-Dec", "meta_volume": "34", "meta_issue": "5-6", "meta_pages": "201-9", "score": 50052.816, "text_hl": "Injection of @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@STZ@@@ produced severe @DISEASE_Glycosuria @DISEASE_MESH:D006029 @@@glycosuria@@@ (> 2%), @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@, hypoinsulnaemia, polydypsia, @DISEASE_Hyperphagia @DISEASE_MESH:D006963 @@@polyphagia@@@ and @DISEASE_Body_Weight @DISEASE_MESH:D001835 @@@loss of body weight@@@. ", "citations": {"NLM": "Sevak AR, Goyal RK. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats. Pharmacol Res. 1996 Nov-Dec;34(5-6):201-9. PMID: 9076844", "BibTeX": "@article{9076844, title={Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.}, author={Sevak AR and Goyal RK}, journal={Pharmacol Res}, volume={34}, number={5-6}, pages={201-9}}"}}, {"_id": "17955176", "pmid": 17955176, "title": "Pancreatic islet beta-cell deficit and glucose intolerance in rats with uninephrectomy.", "journal": "Cell Mol Life Sci", "authors": ["Sui Y", "Zhao HL", "Ma RC", "Ho CS", "Kong AP", "Lai FM", "Ng HK", "Rowlands DK", "Chan JC", "Tong PC"], "date": "2007-12-01T00:00:00Z", "doi": "10.1007/s00018-007-7395-1", "meta_date_publication": "2007 Dec", "meta_volume": "64", "meta_issue": "23", "meta_pages": "3119-28", "score": 50045.996, "text_hl": "Histological staining revealed an islet beta-cell deficit associated with increased immunoreactivity for angiotensin and angiotensin type 1 receptor in UNX @SPECIES_10116 @@@rats@@@. Treatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ significantly improved @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@renal dysfunction@@@, @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@, insulin secretion and islet RAS expression. ", "citations": {"NLM": "Sui Y, Zhao HL, Ma RC, Ho CS, Kong AP, Lai FM, Ng HK, Rowlands DK, Chan JC, Tong PC. Pancreatic islet beta-cell deficit and glucose intolerance in rats with uninephrectomy. Cell Mol Life Sci. 2007 Dec;64(23):3119-28. PMID: 17955176", "BibTeX": "@article{17955176, title={Pancreatic islet beta-cell deficit and glucose intolerance in rats with uninephrectomy.}, author={Sui Y and Zhao HL and Ma RC and Ho CS and Kong AP and Lai FM and Ng HK and Rowlands DK and Chan JC and Tong PC}, journal={Cell Mol Life Sci}, volume={64}, number={23}, pages={3119-28}}"}}, {"_id": "25263930", "pmid": 25263930, "title": "Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.", "journal": "Pharmacol Res", "authors": ["Balakumar P", "Varatharajan R", "Nyo YH", "Renushia R", "Raaginey D", "Oh AN", "Akhtar SS", "Rupeshkumar M", "Sundram K", "Dhanaraj SA"], "date": "2014-12-01T00:00:00Z", "doi": "10.1016/j.phrs.2014.08.008", "meta_date_publication": "2014 Dec", "meta_volume": "90", "meta_issue": "", "meta_pages": "36-47", "score": 50043.78, "text_hl": "@CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@Fenofibrate@@@, but not @CHEMICAL_Dipyridamole @CHEMICAL_MESH:D004176 @@@dipyridamole@@@, significantly prevented the @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ alteration and importantly the @CHEMICAL_Uric_Acid @CHEMICAL_MESH:D014527 @@@uric acid@@@ elevation in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@. @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ (5mg/kg, p.o., 4 weeks, reference compound), prevented the @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@, @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ alteration and development of @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@. ", "citations": {"NLM": "Balakumar P, Varatharajan R, Nyo YH, Renushia R, Raaginey D, Oh AN, Akhtar SS, Rupeshkumar M, Sundram K, Dhanaraj SA. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats. Pharmacol Res. 2014 Dec;90():36-47. PMID: 25263930", "BibTeX": "@article{25263930, title={Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.}, author={Balakumar P and Varatharajan R and Nyo YH and Renushia R and Raaginey D and Oh AN and Akhtar SS and Rupeshkumar M and Sundram K and Dhanaraj SA}, journal={Pharmacol Res}, volume={90}, pages={36-47}}"}}]}